Abstract: A device for cancer therapy comprises one or more magnets. The one or more magnets oscillate on a first axis and a second axis substantially orthogonal to the first axis. The device also comprises a controller configured to oscillate the one or more magnets wherein the oscillating frequency reaches a maximum of 50-350 Hz, and, the oscillation of the one or more magnets is at intervals such that the oscillation duration is in a range of 10 milliseconds to 5 seconds, and the duration of an interval between oscillations is in a range of 10 milliseconds to 10 minutes.

Abstract: A device for cancer therapy comprises one or more means for producing a magnetic field, where the one or more means for producing a magnetic field oscillate on a first axis and a second axis substantially orthogonal to the first axis. The device further comprises a controller configured to oscillate the means for producing a magnetic field wherein the oscillating frequency reaches a maximum of 50-350 Hz, and, the oscillation of the one or more magnetic fields is at intervals such that the oscillation duration is in a range of 10 milliseconds to 5 seconds, and the duration of an interval between oscillations is in a range of 10 milliseconds to 10 minutes.

Abstract: To disrupt mitochondrial function in certain cells, controlling hardware causes a magnet to oscillate so as to generate an oscillating magnetic field. The oscillating magnetic field is applied to a volume of tissue including cells with degraded mitochondria to trigger apoptosis in the cells with degraded mitochondria.

Abstract: To disrupt mitochondrial function in certain cells, controlling hardware causes a magnet to oscillate so as to generate an oscillating magnetic field. The oscillating magnetic field is applied to a volume of tissue including cells with degraded mitochondria to trigger apoptosis in the cells with degraded mitochondria.

Abstract: To disrupt mitochondrial function in certain cells, controlling hardware causes a magnet to oscillate so as to generate an oscillating magnetic field. The oscillating magnetic field is applied to a volume of tissue including cells with degraded mitochondria to trigger apoptosis in the cells with degraded mitochondria.

Abstract: A method for disrupting mitochondrial function in cells includes causing one or more magnets to oscillate along at least a first axis of rotation and a second axis of rotation substantially orthogonal to the first axis of rotation, so as to generate an oscillating magnetic field. To this end, the method includes selecting the first axis of rotation, applying an oscillation pattern along the first axis of rotation, the oscillating including a ramp-up period for an oscillation frequency, a ramp-down period for the oscillation frequency, and an inactive period following the ramp-down period, selecting the second axis of rotation, and applying the oscillation pattern along the second axis of rotation. The method further includes applying the oscillating magnetic field to a tissue comprising cancer cells to trigger apoptosis in the cancer cells.

Abstract: To disrupt mitochondrial function in certain cells, controlling hardware causes a magnet to oscillate so as to generate an oscillating magnetic field. The oscillating magnetic field is applied to a volume of tissue including cells with degraded mitochondria to trigger apoptosis in the cells with degraded mitochondria.

Abstract: The disclosure provides methods of cancer treatment and apparatus and, more particularly, to non-invasive cancer treatments utilizing oscillating magnetic fields to disrupt mitochondrial function or induce apoptosis or another mechanism of cell death in cancer cells. The disclosure also provides a device for providing an OMF treatment to a subject.

Abstract: The disclosure provides methods of cancer treatment and apparatus and, more particularly, to non-invasive cancer treatments utilizing oscillating magnetic fields to disrupt mitochondrial function or induce apoptosis or another mechanism of cell death in cancer cells. The disclosure also provides a device for providing an OMF treatment to a subject.

Abstract: To disrupt mitochondrial function in certain cells, controlling hardware causes a magnet to oscillate so as to generate an oscillating magnetic field. The oscillating magnetic field is applied to a volume of tissue including cells with degraded mitochondria to trigger apoptosis in the cells with degraded mitochondria.